Skip to content

Brent Stead

CEO, Specific Biologics

Brent is co-founder and CEO of Specific Biologics, a discovery stage company developing gene editing technologies for therapeutic use. Prior to Specific Biologics, Brent worked for 7 years in the biotechnology industry in various capacities, most recently in business development for a biologics development and manufacturing organization. He started his career in the life sciences as a Ph.D. graduate of Western University’s biochemistry program and completed his MBA at the Richard Ivey School of Business.